AS ONE Corporation

7476.T
Medical Distribution
2026/02/17 Updated
Market Cap: $1.0B (¥158.9B)
Stock Price: $14.52 (¥2,230)
Exchange Rate: 1 USD = ¥153.61

Fiscal Year Ending March 2026 Q3 Earnings Digest

For the third quarter of the fiscal year ending March 2026, net sales reached 79,204 million yen (Year-over-Year +5.1%), operating income was 9,435 million yen (Year-over-Year +12.4%), and quarterly net income was 6,715 million yen (Year-over-Year +12.4%), all marking record highs.

Importance:
Page Updated: January 30, 2026
IR Disclosure Date: January 30, 2026

Key Figures

  • Net Sales: 79,204 million yen (Year-over-Year +5.1%)
  • Operating Income: 9,435 million yen (Year-over-Year +12.4%)
  • Quarterly Net Income: 6,715 million yen (Year-over-Year +12.4%)

AI要約

Overview of Business Performance

In the third quarter of the fiscal year ending March 2026, net sales amounted to 79,204 million yen (Year-over-Year +5.1%), operating income was 9,435 million yen (Year-over-Year +12.4%), and quarterly net income was 6,715 million yen (Year-over-Year +12.4%), all achieving record highs. The gross profit margin improved by 0.3 percentage points Year-over-Year to 30.6%. Efforts to control logistics expenses and improve profitability have been effective.

Progress by Segment and Initiatives

By segment, the Lab & Industry division maintained strong performance with 66,616 million yen in net sales (Year-over-Year +6.8%), while the Medical division recorded 12,164 million yen (Year-over-Year -3.1%). The e-commerce growth strategy, a key measure in the medium-term plan, saw substantial expansion to 27,384 million yen (Year-over-Year +10.7%). The progress of initiatives such as e-commerce, services, proprietary products, and web-only listings is generally favorable against plans.

Net Sales Trend (Q3)

Operating Income Trend (Q3)

Segment Net Sales Breakdown (Q3 Actual)

Gross Profit Margin Trend (Q3)

Ordinary Income & Quarterly Net Income Trend (Q3)

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.